جميع الدراسات
التوظيفالمرحلة الرابعةتداخلي

DEsogestrel for Bleeding on the Implant (DEBI)

This study, called DEBI, aims to find a better way to help people who experience frustrating bleeding while using the contraceptive implant. The implant is highly effective at preventing pregnancy, but many people have it removed early due to period problems. We're comparing desogestrel, a hormone-only tablet, with the combined oral contraceptive pill (COCP), which contains two hormones. Desogestrel might be safer, cheaper, and easier to access for some. The research wants to see if desogestrel is just as good as the COCP in stopping problem bleeding within 90 days. If it is, it could provide a new, improved treatment option for many implant users.

نظرة سريعة

الحالة
التوظيف
المرحلة
المرحلة الرابعة
الراعي
جامعة نوتنغهام
الهدف من التسجيل
690
ابدأ
30 سبتمبر 2025
التاريخ المتوقع للانتهاء
30 أبريل 2027

ما هو موضوع هذه الدراسة؟

The contraceptive implant is a small rod placed under the skin of your arm that's incredibly good at preventing pregnancy – more than 99% effective. However, a common issue for some people using it is bothersome and unpredictable bleeding or spotting. This can be so frustrating that about a quarter of users decide to have their implant removed early, which can sometimes lead to unplanned pregnancies.

Currently, doctors often suggest taking the combined oral contraceptive pill (COCP) to try and sort out this bleeding. Our study is looking at another treatment option: desogestrel. This is a "mini-pill" that only contains one type of hormone, unlike the COCP which has two. Desogestrel might be a more suitable option for some people, especially those who can't take the combined pill or prefer not to. It's also potentially safer and more affordable, and doesn't require the regular blood pressure and weight checks needed for the combined pill.

The main goal of this research is to see if desogestrel is just as good as the combined pill at reducing problem bleeding within 90 days. If it is, it could mean a simpler, safer, and easier-to-get treatment for people struggling with bleeding while on the implant. This could help more people continue using this very effective form of contraception.

النقاط الرئيسية

  • Exploring new ways to manage problematic bleeding with the contraceptive implant.
  • Comparing desogestrel (mini-pill) with the combined pill (COCP).
  • Aims to find a safer, simpler, and more accessible treatment.
  • Participation involves taking daily tablets and keeping a bleeding diary for 90 days.
  • No extra clinic visits needed; designed to be easy for participants.

من قد يكون مؤهلاً؟

This study is looking for around 690 people who are currently using the contraceptive implant and are experiencing bothersome bleeding. You need to be between 16 and 45 years old and have had your implant in for at least 3 months but no longer than 24 months.

"Problem bleeding" simply means any bleeding (like spotting or heavy bleeding) that you find disruptive or concerning. You'll need to be willing to keep a daily diary of your bleeding throughout the study.

There are some reasons why you might not be able to join, such as if you recently used certain medications or hormones that affect your period, have had certain types of surgery, or have specific medical conditions. The study team will check all these details carefully to make sure the study is right for you.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. Are you between 16 and 45 years old?
  2. Do you currently have a contraceptive implant?
  3. Has your implant been in for at least 3 months, but no more than 2 years?
  4. Are you experiencing bleeding with your implant that you find problematic?
  5. Are you willing to keep a daily bleeding diary?
  6. Can you provide your informed consent to participate?
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

If you join the study, you'll be randomly given either desogestrel tablets or combined oral contraceptive pill tablets to take. You'll take these tablets daily for 90 days.

The main thing you'll need to do is keep a simple daily diary about your bleeding throughout this period. The study has been designed to reduce the time commitment for you, so these daily diaries and a few short questions about taking your medication will be the main task. There aren't any extra doctor's appointments or follow-up visits needed for the study beyond your usual care. The total active participation in terms of taking medication and recording information will be mainly for the 90 days.

المخاطر والفوائد المحتملة

Taking part in this study could help us find a better, simpler treatment for implant-related bleeding, potentially benefiting many people in the future. You will receive either desogestrel or the combined pill, which are both established medications for contraception. However, in this study, they are being used specifically to manage implant-related bleeding. Both medications have known side effects, which will be fully explained to you in detail by the study doctor and in the patient information sheets. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

المواقع (25)

  • مستشفيات جامعة نوتنغهام التابعة لخدمة الصحة الوطنية
    المدينة فقط
    نوتنغهام، إنجلترا
  • Leeds Community Healthcare NHS Trust
    تقريبي
    ليدز، إنجلترا
  • Cambridgeshire Community Services NHS Trust
    المدينة فقط
    St. Ives, England
  • مستشفيات جامعة ساسكس التابعة لمؤسسة الخدمات الصحية الوطنية
    المدينة فقط
    Worthing, England
  • Hampshire and Isle of Wight Healthcare NHS Foundation Trust
    المدينة فقط
    Southampton, England
  • University of Nottingham Health Service
    غير مؤكد
    نوتنغهام، إنجلترا
  • Kingston and Richmond NHS Foundation Trust
    غير مؤكد
    Kingston upon Thames, England
  • Northamptonshire Healthcare NHS Foundation Trust
    غير مؤكد
    Kettering, England
  • مؤسسة مستشفيات جامعة برمنغهام التابعة لهيئة الخدمات الصحية الوطنية
    غير مؤكد
    برمنغهام، إنجلترا
  • مؤسسة مستشفيات جامعة ليفربول التابعة لهيئة الخدمات الصحية الوطنية
    غير مؤكد
    Liverpool, England
  • مؤسسة الرعاية الصحية بجامعة لندن نورث ويست NHS
    غير مؤكد
    هارو، إنجلترا
  • The Royal Wolverhampton NHS Trust
    غير مؤكد
    Wolverhampton, England

أسئلة شائعة

What is the contraceptive implant?

It's a small, flexible rod placed under the skin of your arm that releases hormones to prevent pregnancy for up to 3 years. It's very effective.

What kind of bleeding is considered 'problem bleeding'?

It's any bleeding, like spotting or heavy periods, that you personally find frustrating or bothersome while using your implant.

هل سأعرف أي علاج سأحصل عليه؟

The study is 'blinded', meaning you won't know if you're taking desogestrel or the combined pill until the study is over. This helps ensure fair results.

Do I have to visit the clinic often?

No, there are no extra follow-up visits specifically for the study, beyond any appointments you'd usually have with your doctor.

ماذا لو غيرت رأيي بشأن المشاركة؟

You are free to leave the study at any point, and you don't need a reason. Your usual medical care will not be affected.

كيفية معرفة المزيد

Jo Brooks

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

هل أنت مهتم بالمشاركة؟

سجل اهتمامك

شارك تفاصيلك وفريق البحث لـ "DEsogestrel for Bleeding on the Implant (DEBI)… "سيتواصل معك إذا كنت مؤهلاً. تحدث دائمًا إلى طبيبك قبل الموافقة على المشاركة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.